Centessa Pharmaceuticals (CNTA)

• Market cap: $3.07B
• 1 day: -3.15%
• 5 days: -11.16%
• 1 month: -4.33%
• 3 months: 28.75%
• 6 months: 82.66%
• Year to date: 26.4%
• 1 year: 37.05%
• 5 years: 1.7%
• 10 years: 1.7%
• Sector: Healthcare
• Industry: Biotechnology

About: Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

Employees: 114